Victor Evian

Victor Evian is a VC BioMedTech Analyst at Truffle Capital since March 2024, following a role as a VC Analyst intern at Newfund from July 2023 to February 2024. Prior experiences include working as a Visiting Researcher at Harvard Medical School, where Victor completed a Master's Thesis on biomechanical analysis with the highest grade. Earlier, Victor served as a VC Analyst at Crédit Mutuel Innovation, focusing on health technology, and conducted research in cyber security at ERCOM (THALES Group). Victor holds a Master of Science in Mechanical Engineering, specialized in Biomechanics from EPFL, along with a Bachelor of Science in Mechanical Engineering from the same institution, and an exchange year at Mondragon Unibertsitatea. Academic foundations include a Scientific Baccalaureate with a specialization in Mathematics from Sainte-Croix de Neuilly.